Cargando…

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia

Accumulating evidence shows that disruption of white matter (WM) may be involved in the pathophysiology of schizophrenia, even at the onset of psychosis. However, very few studies have explored sex difference in its association with psychopathology in schizophrenia. This study aims to compare sex di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Xiao-E, Zhu, Daomin, Zhang, Guangya, Du, Xiangdong, Jia, Qiufang, Yin, Guangzhong, Chen, Dachun, Xiu, Meihong, Cao, Bo, Wang, Li, Li, Xiaosi, Soares, Jair C., Zhang, Xiang Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298972/ https://www.ncbi.nlm.nih.gov/pubmed/30563964 http://dx.doi.org/10.1038/s41398-018-0346-9

Ejemplares similares

PM475. White matter abnormalities and their associations with clinical symptoms in first episode and drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

PM505. Impaired glucose tolerance, symptoms and cognitive deficits in first-episode drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study
por: Lei, Wei, et al.
Publicado: (2015)

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia
por: Yang, Mi, et al.
Publicado: (2020)

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
por: Lang, Xiaoe, et al.
Publicado: (2023)

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Ameliorative patterns of grey matter in patients with first-episode and treatment-naïve schizophrenia
por: Li, Mingli, et al.
Publicado: (2023)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
por: Wu, Zhiwei, et al.
Publicado: (2021)

Association of Transferrin Gene Polymorphism with Cognitive Deficits and Psychiatric Symptoms in Patients with Chronic Schizophrenia
por: Chen, Pinhong, et al.
Publicado: (2022)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
por: Wang, Keqiang, et al.
Publicado: (2022)

Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
por: An, Huimei, et al.
Publicado: (2018)

Associations Among Suicidal Ideation, White Matter Integrity and Cognitive Deficit in First-Episode Schizophrenia
por: Long, Yicheng, et al.
Publicado: (2018)

White Matter Alterations in Deficit Schizophrenia
por: Rowland, Laura M., et al.
Publicado: (2008)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2022)

Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia
por: Yang, Mi, et al.
Publicado: (2022)

The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study
por: Liu, Jiahong, et al.
Publicado: (2021)

Depth‐dependent abnormal cortical myelination in first‐episode treatment‐naïve schizophrenia
por: Wei, Wei, et al.
Publicado: (2020)

Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Lin, Chen, et al.
Publicado: (2021)

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism
por: Xia, Haisen, et al.
Publicado: (2019)

The inconsistent mediating effect of catechol O methyl transferase Val(158)Met polymorphism on the sex difference of cognitive impairment in schizophrenia patients
por: Xu, Hang, et al.
Publicado: (2022)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Desynchronized white matter function and structure in drug-naive first-episode major depressive disorder patients
por: Guo, Qinger, et al.
Publicado: (2023)

The common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia
por: Ren, H. Y., et al.
Publicado: (2017)

White matter deficits in schizophrenia are global and don’t progress with age
por: Kanaan, Richard A, et al.
Publicado: (2017)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

Association of Subclinical Hypothyroidism With Anxiety Symptom in Young First-Episode and Drug-Naïve Patients With Major Depressive Disorder
por: Yang, Ruchang, et al.
Publicado: (2022)

O6.3. PATTERNS OF GRAY MATTER ABNORMALITIES IN PATIENTS WITH FIRST-EPISODE AND TREATMENT-NAïVE SCHIZOPHRENIA
por: Li, Mingli, et al.
Publicado: (2018)

Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
por: Wu, Yuxuan, et al.
Publicado: (2022)

Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls
por: Chen, Song, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uriq14m9q0loo3gue3bvep97se